| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2300868 | 口服重组人糜蛋白酶冻干粉 | Other | Biological Products(1) | New Drug Application | 2023-12-16 | Wuhan Healthgen BIOTECHNOLOGY Corp | view |